Provided by Tiger Fintech (Singapore) Pte. Ltd.

IceCure Medical Ltd.

0.8250
-0.0641-7.21%
Post-market: 0.84960.0246+2.98%19:59 EDT
Volume:852.87K
Turnover:728.59K
Market Cap:48.42M
PE:-2.89
High:0.9000
Open:0.8867
Low:0.8240
Close:0.8891
52wk High:1.66
52wk Low:0.4800
Shares:58.70M
Float Shares:30.82M
Volume Ratio:1.02
T/O Rate:2.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2854
EPS(LYR):-0.3011
ROE:-173.47%
ROA:-72.28%
PB:8.07
PE(LYR):-2.74

Loading ...

IceCure Medical Successfully Closes Oversubscribed Rights Offering

TIPRANKS
·
Aug 02

IceCure Medical Ltd. Files Prospectus for Over-Subscribed $10 Million Rights Offering

Reuters
·
Aug 02

Icecure Medical Ltd expected to post a loss of 6 cents a share - Earnings Preview

Reuters
·
Aug 01

IceCure Medical Ltd. Files Prospectus for Rights Offering; SEC Declares Registration Statement Effective

Reuters
·
Jul 29

Icecure Announces Expiration and Results of Approximately Two Times Over-Subscribed Rights Offering for Aggregate Gross Proceeds of $10.0 Million

THOMSON REUTERS
·
Jul 29

IceCure Medical Ltd. Announces Appointment of Yonatan Malca as External Director

Reuters
·
Jul 28

IceCure Medical Ltd. Showcases ProSense® at Japanese Breast Cancer Society Conference with Promising Clinical Data

Reuters
·
Jul 25

IceCure Medical Ltd. Files Prospectus for Rights Offering, Subscription Period Set to Expire on July 28, 2025

Reuters
·
Jul 24

IceCure Medical Announces Shareholder Meeting for August 2025

TIPRANKS
·
Jul 17

IceCure Medical Initiates Rights Offering Amid Financial Challenges

TIPRANKS
·
Jul 10

IceCure Medical Ltd's (NASDAQ:ICCM) Path To Profitability

Simply Wall St.
·
Jul 09

IceCure Medical Reports Preliminary Financial Results Amid Shipment Delays

TIPRANKS
·
Jul 03

IceCure Medical sees Q2 product revenue $525K

TIPRANKS
·
Jul 03

IceCure Medical Reports Preliminary Q2 2025 Results: $1.25M Product Sales, Down from $1.65M in Previous Year Due to Shipment Delays

Reuters
·
Jul 03

IceCure Medical Ltd. Announces $10 Million Rights Offering to Fund Cryoablation Technology Expansion

Reuters
·
Jun 25

IceCure Medical Ltd. Announces U.S. Patent Allowance for Innovative Cryogen Flow Control Technology

Reuters
·
Jun 09

Icecure Medical Price Target Maintained With a $2.50/Share by HC Wainwright & Co.

Dow Jones
·
May 30

Buy Rating for Icecure Medical: Anticipated FDA Approval and Strategic Partnerships Drive Positive Outlook

TIPRANKS
·
May 29

IceCure Medical Reports Q1 2025 Financial Results

TIPRANKS
·
May 29

IceCure Q1 2025 Earnings Call Summary and Q&A Highlights: FDA Engagement and Geographic Expansion

Earnings Call
·
May 28